| 标题 |
 First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study |
| 网址 | |
| DOI |
10.1158/2159-8290.cd-17-1119
doi
|
| 其它 |
期刊：Cancer Discovery 作者：Ryan J. Sullivan; Jeffrey R. Infante; Filip Janku; Deborah Jean Lee Wong; Jeffrey A. Sosman; et al 出版日期：2018-02-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Criminology34
DW
GingerF
老的火龙果
斯文的白玉
渡人舟
anugraphics
Ali
嘻嘻哈哈
12Nightz
Nole
无极微光
tang
温暖的炒饭
自信紫夏
Rita
cdercder
coolru
潇洒的早晨
飞天三叉戟
皖公网安备34019202002308
